Rebecca Taub
Director Madrigal
Seminars
Tuesday 30th September 2025
9:15 am Spotlighting Madrigal’s MASH Breakthrough to Explore the Treatment Success & Benchmark for the Next Therapeutic Era
- Informing on Madrigal’s breakthrough drug to further understand how it succeeded in revolutionizing the MASH treatment landscape, leading to a new standard of care for patients
- Reviewing compelling evidence from robust clinical data and real-world evidence to demonstrate the treatment’s significant effectiveness to inform on treatment decisions and improve patient outcomes
- Examining ongoing research and future directions to accelerate the development of more effective MASH therapies for a cure and better long-term management of the disease
Wednesday 1st October 2025
10:00 am Navigating the Path to the First MASH Therapeutic Approval & Progressing Beyond to Advance Clinical Development Strategies to Expand the Horizon of Approved Drugs
- Delving into the strategic clinical development and trial design methodologies that led to the unprecedented first therapeutic approval in MASH, setting a crucial benchmark for future candidates
- Reviewing the comprehensive clinical data and real-world evidence to demonstrate the significant efficacy and safety profiles that underpin the treatment’s success and inform optimal patient management
- Exploring how lessons learned from Madrigal’s development journey, alongside ongoing research, are influencing the design of subsequent clinical trials and accelerating the pipeline for next-generation MASH therapies
